CHF is stratified into 2 classes based on left ventricular ejection fraction (EF). According to the American College of Cardiology (ACC) and American Heart Association (AHA), CHF with EF <40% is ...

Starting sacubitril/valsartan (Entresto) for recently decompensated heart failure with ejection fraction (EF) over 40% improved a key prognostic marker and, for those in the 40-60% range, clinical ...

LONDON — The benefit of mineralocorticoid receptor antagonists (MRAs) for the treatment of patients with heart failure and mildly reduced or preserved ejection fraction has finally been established in ...

Ejection fraction refers to how much blood the heart pumps out during a contraction. An abnormal ejection fraction can be a sign of heart failure. Some people might need treatment to improve their ...

Objective: To provide an overview of heart failure with preserved ejection fraction (HFPEF), as well as its pathophysiology, diagnosis, and clinical evidence regarding its pharmacologic management.

Nihar R. Desai, MD, MPH, and Om P. Ganda, MD, discuss care pathways and the clinical utility of SGLT2 inhibitors and GLP-1 receptor agonists in heart failure. Neil Minkoff, MD: How do you as ...

Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death among patients with chronic heart failure and a left ventricular ...

Patients' willingness to be informed on cancer clinical trials. Background: Routine EF measurement in DLBCL patients prior to ABC is recommended by the National Comprehensive Cancer Network and an ...